Redux

---

Redux was approved in 1996 and withdrawn on Sept. 15, 1997, after heart valve damage was detected in patients using the drug. There is evidence, however, that the dangers of the drug were known for some time. In 1995, while the drug was in the approval stage, the lead FDA medical officer reviewing Redux believed the drug had low effectiveness and very high risk for neurotoxicity and pulmonary hypertension. The FDA nevertheless decided to approve the drug. During its one year on the market, Redux generated sales of $ 255.3 million. Since its approval, however, there have been 123...MORE >>

---

Related Information PPH: Redux FAQ on Heart Valve Disease Redux/Pondimin Settlement Agreement

Links and Resources Heart Info RxList PPH Newsletter View Complete List >>

---

Featured Articles on Redux

• May 17, 2004 - Texas judge affirms $1 billion award in diet drug case
• April 20, 2004 - Majority Counsel Says Fen-Phen Trust Fund is Bust
• November 24, 2003 - 'Fen-Phen' Trust Seeks to Toss Claims
• May 21, 2003 - Thousands of Fen-Phen Patients Opt-Out of Class Action
• September 10, 2001 - Deaths, lawsuits on rise as Fen-Phen/Redux withdrawal approaches 4-year anniversary; cases against diet drug manufacturer could double
• June 12, 2001 - Drug folks ride the death trail of obesity epidemic
• November 14, 2000 - Case Study: The diet drug Redux
• August 29, 2000 - Judge oks settlement on diet drug linked to heart valve damage

---

Browse Books About Drug Litigation

1.The Drug Lords : America's...

2.Deadly Drug Interactions : The People's...

3.The Pdr Family Guide to Prescription...

4.The Essential Guide to Prescription...

5.2001 Mosby's GenRx: A Comprehensive...

6.The American Pharmaceutical...

---

The information you obtain at this site is not, nor is it intended to be, legal advice. You should consult an attorney for individual advice regarding your own situation.